Cargando…
Interaction of Styrylpyridinium Compound with Pathogenic Candida albicans Yeasts and Human Embryonic Kidney HEK-293 Cells
Candida albicans-caused local and systemic diseases are a serious health issue worldwide, leading to high mycosis-associated morbidity and mortality. Efficient combinations of novel compounds with commonly used antifungals could be an important tool for fighting infections. The aim of this study was...
Autores principales: | Vaitkienė, Simona, Bekere, Laura, Duburs, Gunars, Daugelavičius, Rimantas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823387/ https://www.ncbi.nlm.nih.gov/pubmed/33375480 http://dx.doi.org/10.3390/microorganisms9010048 |
Ejemplares similares
-
Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes
por: Vaitkienė, Simona, et al.
Publicado: (2020) -
Styrylpyridinium Derivatives for Fluorescent Cell Imaging
por: Putralis, Reinis, et al.
Publicado: (2023) -
Impact of lipopolysaccharides on cultivation and recombinant protein expression in human embryonal kidney (HEK‐293) cells
por: Faust, Christine, et al.
Publicado: (2021) -
MFS transportome of the human pathogenic yeast Candida albicans
por: Gaur, Manisha, et al.
Publicado: (2008) -
(E)-1-Methyl-2-styrylpyridinium iodide
por: Fun, Hoong-Kun, et al.
Publicado: (2009)